项目编号

PRJCA028109

项目标题

Safety and Feasibility of a 41BB Co-stimulated CD19 CAR-NK Cell Therapy in Refractory/relapsed Large B-cell Lymphoma

涉及领域

Medical

先导项目

IDP: The Immunity Deciphering Project

数据类型

Single cell sequencing

物种名称

Homo sapiens

描述信息

Clinical study of cord blood-derived CARNK cells in the treatment of B-cell lymphoma

样品范围

Single cell

发布日期

2024-11-15

出版信息

PubMed ID	文章标题	杂志名称	Doi	发表年份
			10.1038/s41421-023-00625-0
	Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial	Nature Cancer	10.1038/s43018-025-00940-3	2025

项目资金来源

机构	项目类型	授权项目ID	授权项目名称
Science Technology Department of Zhejiang Province	Key Program	2021C03117	Basic and translational research on the development of novel CAR-NK cells modified with safety switches and the treatment of B-cell lymphoma

提交者

Wenbin Qian (qianwb@zju.edu.cn)

提交单位

The Second Affiliated Hospital, Zhejiang University School of Medicine

提交日期

2024-07-16

项目包含数据信息